organophosphonates has been researched along with Cow Pox in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (94.12) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auw-Haedrich, C; Graef, S; Kern, WV; Kurth, A; Nitsche, A; Plange, N; Reinhard, T | 1 |
| Bailey, KW; Sidwell, RW; Smee, DF | 3 |
| Baker, R; Bray, M; Roy, CJ; Washburn, K | 1 |
| Collins, DJ; Kern, ER; Quenelle, DC | 2 |
| Beadle, JR; Collins, DJ; Hostetler, KY; Kern, ER; Quenelle, DC; Wan, WB | 1 |
| Allen, SD; Knorr, CW; Smee, DF; Torres, AR | 1 |
| Aldern, KA; Beadle, JR; Hartline, CB; Hostetler, KY; Keith, KA; Kern, ER; Ruiz, JC | 1 |
| Garrison, A; Goff, A; Lawler, J; Mucker, E; Paragas, J; Twenhafel, N | 1 |
| Beadle, JR; Collins, DJ; Herrod, BP; Hostetler, KY; Keith, KA; Kern, ER; Quenelle, DC; Trahan, J | 1 |
| Baldwin, TJ; Gowen, BB; Hoopes, JD; Sidwell, RW; Skirpstunas, RT; Smee, DF; Wandersee, MK; Wong, MH | 1 |
| Papavassiliou, VG; Pierroutsakos, IN; Vorou, RM | 1 |
| Bray, M; Huggins, JW; Kefauver, D; Martinez, M; Smee, DF; Thompson, E | 1 |
| Bailey, KW; Sidwell, RW; Smee, DF; Wong, M | 1 |
| Bray, M; Kefauver, D; Martinez, M; Roy, C; West, M | 1 |
1 review(s) available for organophosphonates and Cow Pox
| Article | Year |
|---|---|
Cowpox virus infection: an emerging health threat.
Topics: Animals; Antiviral Agents; Cats; Cidofovir; Communicable Diseases, Emerging; Cowpox; Cowpox virus; Cytosine; Humans; Organophosphonates; Zoonoses | 2008 |
16 other study(ies) available for organophosphonates and Cow Pox
| Article | Year |
|---|---|
Clinicopathological findings in persistent corneal cowpox infection.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Corneal Ulcer; Cowpox; Cowpox virus; Cytosine; DNA, Viral; Eye Infections, Viral; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Middle Aged; Mycophenolic Acid; Organophosphonates; Real-Time Polymerase Chain Reaction; Reoperation; Virus Activation; Visual Acuity | 2013 |
Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox; Cytosine; Female; Infusions, Parenteral; Liver; Lung Diseases; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Vaccinia | 2003 |
Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.
Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Cidofovir; Cowpox; Cowpox virus; Cytosine; Female; Injections, Subcutaneous; Kidney; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Respiratory System; Tissue Distribution | 2003 |
Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Viral; Female; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vero Cells | 2003 |
Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Cidofovir; Cowpox; Cowpox virus; Cytosine; Ethers; Female; Lipids; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vaccinia virus; Viral Load; Virus Replication | 2004 |
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
Topics: Administration, Cutaneous; Animals; Antiviral Agents; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Mice; Organophosphonates; Organophosphorus Compounds; Orthopoxvirus; Vaccinia; Vaccinia virus | 2004 |
Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection.
Topics: Animals; Antiviral Agents; Cidofovir; Cowpox; Cytokines; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Vaccinia; Vaccinia virus | 2006 |
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cowpox; Cytomegalovirus Infections; Cytosine; Herpes Simplex; HIV-1; Humans; In Vitro Techniques; Molecular Structure; Organophosphonates; Sensitivity and Specificity; Vaccinia | 2007 |
In vivo imaging of cidofovir treatment of cowpox virus infection.
Topics: Animals; Antiviral Agents; Bioterrorism; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; DNA Replication; Drug Evaluation, Preclinical; Female; Green Fluorescent Proteins; Humans; Image Processing, Computer-Assisted; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Organophosphonates; Recombination, Genetic; Smallpox; Treatment Outcome; Vero Cells; Virus Replication | 2007 |
Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cowpox; Kidney; Liver; Lung; Mice; Molecular Structure; Organophosphonates; Spleen; Vaccinia virus | 2007 |
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Body Weight; Chemokines; Cidofovir; Cowpox; Cowpox virus; Cytokines; Cytosine; Female; Giant Cells; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates | 2008 |
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Bronchi; Cidofovir; Cowpox; Cytosine; Female; Hemorrhage; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pulmonary Alveoli; Smallpox; Vaccination | 2000 |
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Respiratory Tract Infections; Ribavirin; Vero Cells; Viral Plaque Assay | 2000 |
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Female; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Respiratory System; Respiratory Tract Infections; Vero Cells; Viral Plaque Assay | 2000 |
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
Topics: Administration, Inhalation; Aerosols; Animals; Antiviral Agents; Body Weight; Bronchopneumonia; Cidofovir; Cowpox; Cowpox virus; Cytosine; Female; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates; Organophosphorus Compounds; Statistics, Nonparametric | 2002 |
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Topics: Animals; Antiviral Agents; Area Under Curve; Body Weight; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Nasal Mucosa; Organophosphonates; Organophosphorus Compounds; Prodrugs; Purines; Statistics, Nonparametric; Vero Cells | 2002 |